|
1
|
Rivera C: Essentials of oral cancer. Int J
Clin Exp Pathol. 8:11884–11894. 2015.PubMed/NCBI
|
|
2
|
Choi S and Myers JN: Molecular
pathogenesis of oral squamous cell carcinoma: Implications for
therapy. J Dent Res. 87:14–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta PC: Mouth cancer in India: A new
epidemic? Indian Med Assoc. 97:370–373. 1999.
|
|
4
|
Mehrotra R, Singh M, Kumar D, Pandey AN,
Gupta RK and Sinha US: Age specific incidence rate and pathological
spectrum of oral cancer in Allahabad. Indian J Med Sci. 57:400–404.
2003.PubMed/NCBI
|
|
5
|
Lingen MW, Kalmar JR, Karrison T and
Speight PM: Critical evaluation of diagnostic aids for the
detection of oral cancer. Oral Oncol. 44:10–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'neill V and Twelves C: Oral cancer
treatment: Developments in chemotherapy and beyond. Br J Cancer.
87:933–937. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ries LAG, Melbert D, Krapcho M, Stinchcomb
DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ and
Altekruse SF: SEER Cancer Statistics Review, 1975–2005 (Based on
November 2007 SEER data submission). National Cancer Institute;
Bethesda, MD: 2008
|
|
8
|
Du T and Zamore PD: microPrimer: The
biogenesis and function of microRNA. Development. 132:4645–4652.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 1–774. 1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Manikandan M, Rao AKDM, Arunkumar G,
Manickavasagam M, Rajkumar KS, Rajaraman R and Munirajan AK: Oral
squamous cell carcinoma: microRNA expression profiling and
integrative analyses for elucidation of tumourigenesis mechanism.
Mol Cancer. 15:282016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song B, Ji W, Guo S, Liu A, Jing W, Shao
C, Li G and Jin G: miR-545 inhibited pancreatic ductal
adenocarcinoma growth by targeting RIG-I. FEBS Lett. 588:4375–4381.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du B, Wang Z, Zhang X, Feng S, Wang G, He
J and Zhang B: MicroRNA-545 suppresses cell proliferation by
targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One.
9:e880222014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Ftx non coding RNA-derived
miR-545 promotes cell proliferation by targeting RIG-I in
hepatocellular carcinoma. Oncotarget. 7:25350–25365.
2016.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immuno Methods. 65:55–63. 1983. View Article : Google Scholar
|
|
17
|
Roehm NW, Rodgers GH, Hatfield SM and
Glasebrook AL: An improved colorimetric assay for cell
proliferation and viability utilizing the tetrazolium salt XTT. J
Immunol Methods. 142:257–265. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gerlier D and Thomasset N: Use of MTT
colorimetric assay to measure cell activation. J Immunol Methods.
94:57–63. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berridge MV, Tan AS, McCoy KD and Wang R:
The biochemical and cellular basis of cell proliferation assays
that use tetrazolium salts. Biochemica. 4:14–19. 1996.
|
|
20
|
Weichert H, Blechschmidt I, Schröder S and
Ambrosius H: The MTT-assay as a rapid test for cell proliferation
and cell killing: Application to human peripheral blood lymphocytes
(PBL). Allergie Immunol (Leipz). 37:139–144. 1991.
|
|
21
|
Rüster B, Grace B, Seitz O, Seifried E and
Henschler R: Induction and detection of human mesenchymal stem cell
migration in the 48-well reusable transwell assay. Stem Cells Dev.
14:231–235. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hornung V, Ellegast J, Kim S, Brzózka K,
Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, et al:
5′-Triphosphate RNA is the ligand for RIG-I. Science. 314:994–997.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia X, Liu X, Li M, Zeng Y, Feng Z, Su X,
Huang Y, Chen M and Yang X: Potential tumor suppressing role of
microRNA-545 in epithelial ovarian cancer. Oncol Lett.
15:6386–6392. 2018.PubMed/NCBI
|
|
24
|
Pichlmair A, Schulz O, Tan CP, Näslund TI,
Liljeström P, Weber F and Reis e Sousa C: RIG-I-mediated antiviral
responses to single-stranded RNA bearing 5′-phosphates. Science.
314:997–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chiu YH, Macmillan JB and Chen ZJ: RNA
polymerase III detects cytosolic DNA and induces type I interferons
through the RIG-I pathway. Cell. 138:576–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ablasser A, Bauernfeind F, Hartmann G,
Latz E, Fitzgerald KA and Hornung V: RIG-I-dependent sensing of
poly(dA:dT) through the induction of an RNA polymerase
III-transcribed RNA intermediate. Nat Immunol. 10:1065–1072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gan LL, Zhang H, Guo JH and Fan MW:
Prevalence of human papillomavirus infection in oral squamous cell
carcinoma: A case-control study in Wuhan, China. Asian Pac J Cancer
Prev. 15:5861–5865. 2014. View Article : Google Scholar : PubMed/NCBI
|
